<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37301958</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function.</ArticleTitle><Pagination><StartPage>377</StartPage><MedlinePgn>377</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">377</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-023-04149-9</ELocationID><Abstract><AbstractText Label="AIMS">Long-COVID occurs after SARS-CoV-2 infection and results in diverse, prolonged symptoms. The present study aimed to unveil potential mechanisms, and to inform prognosis and treatment.</AbstractText><AbstractText Label="METHODS">Plasma proteome from Long-COVID outpatients was analyzed in comparison to matched acutely ill COVID-19 (mild and severe) inpatients and healthy control subjects. The expression of 3072 protein biomarkers was determined with proximity extension assays and then deconvoluted with multiple bioinformatics tools into both cell types and signaling mechanisms, as well as organ specificity.</AbstractText><AbstractText Label="RESULTS">Compared to age- and sex-matched acutely ill COVID-19 inpatients and healthy control subjects, Long-COVID outpatients showed natural killer cell redistribution with a dominant resting phenotype, as opposed to active, and neutrophils that formed extracellular traps. This potential resetting of cell phenotypes was reflected in prospective vascular events mediated by both angiopoietin-1 (ANGPT1) and vascular-endothelial growth factor-A (VEGFA). Several markers (ANGPT1, VEGFA, CCR7, CD56, citrullinated histone 3, elastase) were validated by serological methods in additional patient cohorts. Signaling of transforming growth factor-&#x3b2;1 with probable connections to elevated&#xa0;EP/p300 suggested vascular inflammation and tumor necrosis factor-&#x3b1; driven pathways. In addition, a vascular proliferative state associated with hypoxia inducible factor 1 pathway suggested progression from acute COVID-19 to Long-COVID. The vasculo-proliferative process predicted in Long-COVID might contribute to changes in the organ-specific proteome reflective of neurologic and cardiometabolic dysfunction.</AbstractText><AbstractText Label="CONCLUSIONS">Taken together, our findings point to a vasculo-proliferative process in Long-COVID that is likely initiated either prior hypoxia (localized or systemic) and/or stimulatory factors&#xa0;(i.e., cytokines, chemokines, growth factors, angiotensin, etc). Analyses of the plasma proteome, used as a surrogate for cellular signaling, unveiled potential organ-specific prognostic biomarkers and therapeutic targets.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iosef</LastName><ForeName>Cristiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Children's Health Research Institute, Victoria Research Laboratories, 800 Commissioners Road East, London, ON, N6C 2V5, Canada. cristiana.iosef@lhsc.on.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knauer</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, London, ON, N6A 5C1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Western University, London, ON, N6A 5C1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Nynatten</LastName><ForeName>Logan R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Western University, London, ON, N6A 5C1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cepinskas</LastName><ForeName>Gediminas</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Lawson Health Research Institute, London, ON, N6C 2R5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biophysics, Western University, London, ON, N6A 5C1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Draghici</LastName><ForeName>Sorin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computer Science College of Engineering, Wayne State University, Ann Arbor, MI, 48202, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advaita Bioinformatics, Ann Arbor, 48105-2552, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Science Foundation, Alexandria, VA, 22314, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Victor K M</ForeName><Initials>VKM</Initials><AffiliationInfo><Affiliation>Children's Health Research Institute, Victoria Research Laboratories, 800 Commissioners Road East, London, ON, N6C 2V5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Western University, London, ON, N6A 5C1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>Douglas D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Children's Health Research Institute, Victoria Research Laboratories, 800 Commissioners Road East, London, ON, N6C 2V5, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lawson Health Research Institute, London, ON, N6C 2R5, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Western University, London, ON, N6A 5C1, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology &amp; Pharmacology, Western University, London, ON, N6A 5C1, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurological Sciences, Western University, London, ON, N6A 5C1, Canada. douglas.fraser@lhsc.on.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>There are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>11</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37301958</ArticleId><ArticleId IdType="pmc">PMC10257382</ArticleId><ArticleId IdType="doi">10.1186/s12967-023-04149-9</ArticleId><ArticleId IdType="pii">10.1186/s12967-023-04149-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, et al. Pathophysiology and mechanism of Long-COVID: a comprehensive review. Ann Med. 2022;54(1):1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown K, Yahyouche A, Haroon S, Camaradou J, Turner J. Long-COVID and self-management. Lancet. 2022;22(399):10322&#x2013;10355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776283</ArticleId><ArticleId IdType="pubmed">35065779</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization WHO R&amp;D Blueprint. Novel Coronavirus. COVID-19 Therapeutic Trial Synopsis.https://cdn.who.int/media/docs/default-source/blue-print/covid-19-therapeutic-trial-synopsis.pdf?sfvrsn=44b83344_1&amp;download=true.</Citation></Reference><Reference><Citation>Patel MA, Knauer MJ, Nicholson M, Daley M, Van Nynatten LR, Martin C, et al. Elevated vascular transformation blood biomarkers in long-COVID indicate angiogenesis as a key pathophysiological mechanism. Molec Med. 2022;28(1):122. doi: 10.1186/s10020-022-00548-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MA, Knauer MJ, Nicholson M, Daley M, Van Nynatten LR, Cepinskas G, Fraser DD. Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning. Mol Med. 2023;29(1):26. doi: 10.1186/s10020-023-00610-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-023-00610-z</ArticleId><ArticleId IdType="pmc">PMC9942653</ArticleId><ArticleId IdType="pubmed">36809921</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Shiliang L. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. 2022;32(4):e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of Long-COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J, Vogel G. Vaccines may cause rare, long-COVID-like symptoms. Science. 2022;375(6579):364&#x2013;366. doi: 10.1126/science.ada0536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.ada0536</ArticleId><ArticleId IdType="pubmed">35084966</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev. 2022;21(5):103071. doi: 10.1016/j.autrev.2022.103071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103071</ArticleId><ArticleId IdType="pmc">PMC8848724</ArticleId><ArticleId IdType="pubmed">35182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Long-COVID treatments: why the world is still waiting. Nature. 2022;608(7922):258&#x2013;260. doi: 10.1038/d41586-022-02140-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-02140-w</ArticleId><ArticleId IdType="pubmed">35945375</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Boustani K, Ogger PP, Papadaki A, Tonkin J, Orton CM, Ghai P, Suveizdyte K, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022;55(3):542&#x2013;556. doi: 10.1016/j.immuni.2022.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser DD, Miller MR, Martin CM, Slessarev M, Hahn P, Higgins I, et al. Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2020;2(6):e0144. doi: 10.1097/CCE.0000000000000144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000144</ArticleId><ArticleId IdType="pmc">PMC7314329</ArticleId><ArticleId IdType="pubmed">32696007</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E, Du H, Gardner H. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533&#x2013;534. doi: 10.1016/S1473-3099(20)30120-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, et al. Post-acute COVID-19 syndrome. Nat Med Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Taribagil P, Creer D, Tahir D. &#x2018;Long-COVID&#x2019; syndrome. BMJ Case Rep. 2021;14:e241485. doi: 10.1136/bcr-2020-241485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-241485</ArticleId><ArticleId IdType="pmc">PMC8057566</ArticleId><ArticleId IdType="pubmed">33875508</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long-COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, Rustagi A, Zhao NQ, Roque J, Mart&#xed;nez-Col&#xf3;n GJ, McKechnie JL, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med. 2020;26:1070&#x2013;1076. doi: 10.1038/s41591-020-0944-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0944-y</ArticleId><ArticleId IdType="pmc">PMC7382903</ArticleId><ArticleId IdType="pubmed">32514174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, Vlok M, Turner S, Venter C, Laubscher GJ, Kell DB, Pretorius E. Proteomics of fibrin amyloid microclots in Long-COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabeto. 2022;21(1):190. doi: 10.1186/s12933-022-01623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H, R&#xf6;hl A, Freiwald A, Szyrwiel L, Ludwig D, Correia-Melo C, et al. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 2021;12(8):780&#x2013;794. doi: 10.1016/j.cels.2021.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2021.05.005</ArticleId><ArticleId IdType="pmc">PMC8201874</ArticleId><ArticleId IdType="pubmed">34139154</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin MR, et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep Med. 2021;2(5):100287. doi: 10.1016/j.xcrm.2021.100287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100287</ArticleId><ArticleId IdType="pmc">PMC8091031</ArticleId><ArticleId IdType="pubmed">33969320</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, Fenyves BG, Charland NC, Gonye ALK, et al. Novel outcome biomarkers identified with targeted proteomic analyses of plasma from critically Ill coronavirus disease 2019 patients. Cell Rep Med. 2021;2(5):100287. doi: 10.1016/j.xcrm.2021.100287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100287</ArticleId><ArticleId IdType="pmc">PMC8091031</ArticleId><ArticleId IdType="pubmed">33969320</ArticleId></ArticleIdList></Reference><Reference><Citation>Memon D, Barrio-Hernandez I, Beltrao P. Individual COVID-19 disease trajectories revealed by plasma proteomics. EMBO Mol Med. 2021;13(8):e14532. doi: 10.15252/emmm.202114532.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114532</ArticleId><ArticleId IdType="pmc">PMC8687119</ArticleId><ArticleId IdType="pubmed">34260159</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedula P, Tang HY, Speicher DW, Kashina A. Protein posttranslational signatures identified in COVID-19 patient plasma. Front Cell Dev Biol. 2022;10:807149. doi: 10.3389/fcell.2022.807149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.807149</ArticleId><ArticleId IdType="pmc">PMC8873527</ArticleId><ArticleId IdType="pubmed">35223838</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Nesf MAY, Abdesselem HB, Bensmail I, Ibrahim S, Saeed WAH, Mohammed SSI, Razok A, Alhussain H, et al. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications. Nat Commun. 2022;13(1):946. doi: 10.1038/s41467-022-28639-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28639-4</ArticleId><ArticleId IdType="pmc">PMC8854716</ArticleId><ArticleId IdType="pubmed">35177642</ArticleId></ArticleIdList></Reference><Reference><Citation>Feyaerts D, H&#xe9;dou J, Gillard J, Chen H, Tsai ES, Peterson LS, et al. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19. bioRxiv. 2021 doi: 10.1016/j.xcrm.2022.100680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100680</ArticleId><ArticleId IdType="pmc">PMC9238057</ArticleId><ArticleId IdType="pubmed">35839768</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam SM, Zhang C, Wang Z, Ni Z, Zhang S, Yang S, Huang X, Mo L, et al. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat Metab. 2021;3(7):909&#x2013;922. doi: 10.1038/s42255-021-00425-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00425-4</ArticleId><ArticleId IdType="pubmed">34158670</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostron AJ, Simpson AJ, Hambleton S, Laurenti E, Lyons PA, Meyer KB, Nikoli&#x107; MZ, Duncan CJA, Smith KGC, et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021;27(5):904&#x2013;916. doi: 10.1038/s41591-021-01329-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01329-2</ArticleId><ArticleId IdType="pmc">PMC8121667</ArticleId><ArticleId IdType="pubmed">33879890</ArticleId></ArticleIdList></Reference><Reference><Citation>Iosef C, Martin CM, Slessarev M, Gillio-Meina C, Cepinskas G, Han VKM, Fraser DD. COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management. J Cell Mol Med. 2023;27(1):141&#x2013;157. doi: 10.1111/jcmm.17622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17622</ArticleId><ArticleId IdType="pmc">PMC9806290</ArticleId><ArticleId IdType="pubmed">36537107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, Kuri-Cervantes L, Pampena MB, D'Andrea K, Manne S, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):8511. doi: 10.1126/science.abc8511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing AG, Lorenc A, Del Molino Barrio I, Das A, Fish M, Monin L, Mu&#xf1;oz-Ruiz M, McKenzie DR, Hayday TS, Francos-Quijorna I, Kamdar S, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26:1623&#x2013;1635. doi: 10.1038/s41591-020-1038-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1038-6</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser DD, Cepinskas G, Slessarev M, Martin CM, Daley M, Patel MA, et al. Detection and profiling of human coronavirus immunoglobulins in critically Ill coronavirus disease 2019 patients. Crit Care Explor. 2021;3(3):e0369. doi: 10.1097/CCE.0000000000000369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000369</ArticleId><ArticleId IdType="pmc">PMC7994038</ArticleId><ArticleId IdType="pubmed">33786445</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupisella LA, Parvin SS, Wurtz TR, Garcia RA. Formyl peptide receptor 2 and heart disease. Semin Immunol. 2022 doi: 10.1016/j.smim.2022.101602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2022.101602</ArticleId><ArticleId IdType="pubmed">35277300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg M, Eriksson A, Tran B, Assarsson E, Fredrickson S. Homogenous antibody-based proximity ligation assay provides sensitive and specific detection or low abundant proteins in human blood. Nucl Acid Res. 2011;39(15):e102. doi: 10.1093/nar/gkr424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr424</ArticleId><ArticleId IdType="pmc">PMC3159481</ArticleId><ArticleId IdType="pubmed">21646338</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam PS, Wimmers F, Mok CKP, Perera RAPM, Scott M, Hagan T, Sigal N, Feng Y, Bristow L, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369(6508):1210&#x2013;1220. doi: 10.1126/science.abc6261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6261</ArticleId><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller PL, Rohde PD, Winther S, Breining P, Nissen L, Nykjaer A, B&#xf8;ttcher M, Nyegaard M, Kjolby M. Sortilin as a biomarker for cardiovascular disease revisited. Front Cardiovasc Med. 2021;8:652584. doi: 10.3389/fcvm.2021.652584.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.652584</ArticleId><ArticleId IdType="pmc">PMC8085299</ArticleId><ArticleId IdType="pubmed">33937362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Schank M, Wang L, Dang X, Cao D, Khanal S, Nguyen LNT, Zhang Y, Wu XY, Adkins JL, Pelton BJ, et al. Plasma biomarkers for systemic inflammation in COVID-19 survivors. Proteomics Clin Appl. 2022;16(5):e2200031. doi: 10.1002/prca.202200031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.202200031</ArticleId><ArticleId IdType="pmc">PMC9539278</ArticleId><ArticleId IdType="pubmed">35929818</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu T, Ning W, Wu D, Xu J, Han Q, Huang M, Zou X, Yang Q, Yuan Y, Bie Y, Pan S, Mu J, Han Y, et al. Plasma proteomics identify biomarkers and pathogenesis of COVID-19. Immunity. 2020;53(5):1108&#x2013;1122. doi: 10.1016/j.immuni.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.10.008</ArticleId><ArticleId IdType="pmc">PMC7574896</ArticleId><ArticleId IdType="pubmed">33128875</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser DD, Cepinskas G, Patterson EK, Slessarev M, Martin C, Daley M, Patel MA, Miller MR, O'Gorman DB, Gill SE, Pare G, Prassas I, Diamandis E. Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2020;2(9):e0189. doi: 10.1097/CCE.0000000000000189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000189</ArticleId><ArticleId IdType="pmc">PMC7449255</ArticleId><ArticleId IdType="pubmed">32904064</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams SA, Kivimaki M, Langenberg C, Hingorani AD, Casas JP, Bouchard C, Jonasson C, Sarzynski MA, et al. Plasma protein patterns as comprehensive indicators of health. Nat Med. 2019;25(12):1851&#x2013;1857. doi: 10.1038/s41591-019-0665-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0665-2</ArticleId><ArticleId IdType="pmc">PMC6922049</ArticleId><ArticleId IdType="pubmed">31792462</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607&#x2013;D613. doi: 10.1093/nar/gky1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1131</ArticleId><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. A systems biology approach for pathway level analysis. Genome Res. 2007;17(10):1537&#x2013;1545. doi: 10.1101/gr.6202607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.6202607</ArticleId><ArticleId IdType="pmc">PMC1987343</ArticleId><ArticleId IdType="pubmed">17785539</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73&#x2013;79. doi: 10.1038/s41586-018-0175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0175-2</ArticleId><ArticleId IdType="pmc">PMC6697541</ArticleId><ArticleId IdType="pubmed">29875488</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafi A, Nguyen T, Peyvandipour A, Nguyen H, Draghici S. A multi-cohort and multi-omics meta-analysis framework to identify network-based gene signatures. Front Genet. 2019;19(10):159. doi: 10.3389/fgene.2019.00159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00159</ArticleId><ArticleId IdType="pmc">PMC6434849</ArticleId><ArticleId IdType="pubmed">30941158</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Shafi A, Nguyen TM, Schissler AG, Draghici S. NBIA: a network-based integrative analysis framework&#x2014;applied to pathway analysis. Sci Rep. 2020;10(1):4188. doi: 10.1038/s41598-020-60981-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-60981-9</ArticleId><ArticleId IdType="pmc">PMC7060280</ArticleId><ArticleId IdType="pubmed">32144346</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Bennett TD, Bhatia A, Brooks IM, Deer RR, Dekermanjian JP, Jolley SE, Kahn MG, Kostka K, et al. N3C Consortium Identifying who has long COVID in the USA a machine learning approach using N3C data. Lancet Digit Health. 2022 doi: 10.1016/S2589-7500(22)00048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453&#x2013;457. doi: 10.1038/nmeth.3337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3337</ArticleId><ArticleId IdType="pmc">PMC4739640</ArticleId><ArticleId IdType="pubmed">25822800</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, Kuri-Cervantes L, Pampena MB, D'Andrea K, Manne S, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):8511. doi: 10.1126/science.abc8511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing AG, Lorenc A, Molino Del, Del Barrio I, Das A, Fish M, Monin L, Mu&#xf1;oz-Ruiz M, McKenzie DR, Hayday TS, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26:1623&#x2013;1635. doi: 10.1038/s41591-020-1038-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1038-6</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh SM. The angiopoietins and Tie in vascular inflammation. Curr Oppinion Hematol. 2017;24(5):432&#x2013;438. doi: 10.1097/MOH.0000000000000361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0000000000000361</ArticleId><ArticleId IdType="pmc">PMC5777595</ArticleId><ArticleId IdType="pubmed">28582314</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, Almire C, H&#xe9;non C, Kosmider O, Droin N, Rameau P, Catelain C, Alfaro A, et al. Elevated calprotection and abnormal myeloid cell subsets discriminate severe from mild COVID19. Cell. 2020;182:1401&#x2013;1418. doi: 10.1016/j.cell.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice CM, Lewis P, Ponce-Garcia FM, Willem Gibbs D, Cela F, et al. Neutrophils in COVID19 are characterized by hyperactive immature state and maintained CXR2 expression. medRix. 2022 doi: 10.1101/2022.03.23.22272828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.23.22272828</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Rosin NL, Arora R, Labit E, Jaffer A, Cao L, Farias R, Nguyen AP, de Almeida LGN, et al. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19. Nat Med. 2022;28(1):201&#x2013;211. doi: 10.1038/s41591-021-01576-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01576-3</ArticleId><ArticleId IdType="pmc">PMC8799469</ArticleId><ArticleId IdType="pubmed">34782790</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5(5):1164&#x2013;1177. doi: 10.1182/bloodadvances.2020003568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003568</ArticleId><ArticleId IdType="pmc">PMC7908851</ArticleId><ArticleId IdType="pubmed">33635335</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZW, Zhang YM, Zhang LY, Zhou T, Li YY, Zhou GC, Miao ZM, et al. Duality of interactions between TGF-&#x3b2; and TNF-&#x3b1; during tumor formation. Front Immunol. 2021 doi: 10.3389/fimmu.12:810286.10.3389/fimmu.2021.810286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.12:810286.10.3389/fimmu.2021.810286</ArticleId><ArticleId IdType="pmc">PMC8766837</ArticleId><ArticleId IdType="pubmed">35069596</ArticleId></ArticleIdList></Reference><Reference><Citation>Portuguez Aj, Grbesa I, Tal M, Deitch R, Raz D, Kliker L, Weismann R, Schwartz M, Loza O, Cohen L, Marchenkov-Flam L, et al. Ep300 sequestration to functionally distinct glucocorticoid receptor binding loci underlie rapid gene activation and repression. Nucl Ac Res. 2022;50(12):6702&#x2013;6714. doi: 10.1093/nar/gkac488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac488</ArticleId><ArticleId IdType="pmc">PMC9262608</ArticleId><ArticleId IdType="pubmed">35713523</ArticleId></ArticleIdList></Reference><Reference><Citation>Dendoncker K, Timmermans S, Vandewalle J, Eggermont M, Lempi&#xe4;inen J, Paakinaho V, Van Hamme E, Dewaele S, Vandevyver S, et al. TNF-&#x3b1; inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile. Proc Natl Acad Sci USA. 2019;116(26):12942&#x2013;12951. doi: 10.1073/pnas.1821565116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1821565116</ArticleId><ArticleId IdType="pmc">PMC6600915</ArticleId><ArticleId IdType="pubmed">31182584</ArticleId></ArticleIdList></Reference><Reference><Citation>Morikawa, et al. Genome-wide mechanisms of Smad binding. Oncogene. 2013;32:1609&#x2013;1615. doi: 10.1038/onc.2012.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2012.191</ArticleId><ArticleId IdType="pmc">PMC3615190</ArticleId><ArticleId IdType="pubmed">22614010</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Msika EF, Queneau M, Farid K, Paquet C. Long-COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. 2022;269(1):44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>ENTREZ: https://www.ncbi.nlm.nih.gov/gene/4088; https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=ShowDetailView&amp;TermToSearch=2033</Citation></Reference><Reference><Citation>Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiat. 2021 doi: 10.1001/jamapsychiatry.2021.0500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Charnley M, Islam S, Bindra GK, Engwirda J, Ratcliffe J, Zhou J, Mezzenga R, Hulett MD, Han K, Berryman JT, Reynolds NP. Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19. Nat Commun. 2022;13(1):3387. doi: 10.1038/s41467-022-30932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30932-1</ArticleId><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="pubmed">35697699</ArticleId></ArticleIdList></Reference><Reference><Citation>Asaduzzaman M, Constantinou S, Min H, Gallon J, Lin ML, Singh P, Raguz S, Ali S, Shousha S, Coombes RC, Lam EW, Hu Y, Yag&#xfc;e E. Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer. Breast Cancer Res Treat. 2018;167(2):605&#x2013;606. doi: 10.1007/s10549-017-4633-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10549-017-4633-6</ArticleId><ArticleId IdType="pmc">PMC6828501</ArticleId><ArticleId IdType="pubmed">29305809</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z, Lan T, Wei Y, Wei X. CCL5/CCR5 axis in human diseases and related treatments. Genes Dis. 2022;9(1):12&#x2013;27. doi: 10.1016/j.gendis.2021.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2021.08.004</ArticleId><ArticleId IdType="pmc">PMC8423937</ArticleId><ArticleId IdType="pubmed">34514075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ring A, Kaur P, Lang JE. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer. BMC Cancer. 2020;20(1):1076. doi: 10.1186/s12885-020-07573-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-020-07573-y</ArticleId><ArticleId IdType="pmc">PMC7653866</ArticleId><ArticleId IdType="pubmed">33167919</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce S, Moretta L, Moretta A, Marcenaro E. Human NK cell subsets redistribution in pathological conditions: a role for CCR7 receptor. Front Immunol. 2016;7(7):414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5053980</ArticleId><ArticleId IdType="pubmed">27774094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito TK, Ishi G, Saito S, Iano K, Suziki T, Ochiai A, Ito TK, Ishi G, Saito S, Iano K, Suziki T, Ochiai A. Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood. 2009;113(10):2363&#x2013;9. doi: 10.1182/blood-2008-08-172742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-08-172742</ArticleId><ArticleId IdType="pubmed">18974372</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Guevara-Coto J, Yogendra R, Francisco EB, Long E, Pise A, Rodrigues H, Parikh P, Mora J, Mora-Rodr&#xed;guez RA. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. 2021;28(12):700782. doi: 10.3389/fimmu.2021.700782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, Hall E, et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front Immunol. 2022;10(12):746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of &#x2018;happy&#x2019; hypoxemia in COVID-19. Respir Res. 2020;21:198. doi: 10.1186/s12931-020-01462-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01462-5</ArticleId><ArticleId IdType="pmc">PMC7385717</ArticleId><ArticleId IdType="pubmed">32723327</ArticleId></ArticleIdList></Reference><Reference><Citation>Akoumianaki E, Vaporidi K, Bolaki M, Georgopoulos D. Happy or silent hypoxia in COVID-19&#x2013;a misnomer born in the pandemic era. Front Physiol. 2021;12:745634. doi: 10.3389/fphys.2021.745634.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.745634</ArticleId><ArticleId IdType="pmc">PMC8558242</ArticleId><ArticleId IdType="pubmed">34733177</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson M. Role of chemokines in the biology of natural killer cells. J Leukoc Biol. 2002;71(2):173&#x2013;183. doi: 10.1189/jlb.71.2.173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.71.2.173</ArticleId><ArticleId IdType="pubmed">11818437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z, Lan T, Wei Y, Wei X. CCL5/CCR5 axis in human diseases and related treatments. Genes Dis. 2022;9(1):12&#x2013;27. doi: 10.1016/j.gendis.2021.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2021.08.004</ArticleId><ArticleId IdType="pmc">PMC8423937</ArticleId><ArticleId IdType="pubmed">34514075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A, Hollenstein M, Shoumariyeh T, Skos L, Reiter B, Gerner MC, Spannbauer A, Hasimbegovic E, Schmidl D, Garh&#xf6;fer G, Gy&#xf6;ngy&#xf6;si M, Schmetterer KG, Gerner C. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience. 2023;26(1):105717. doi: 10.1016/j.isci.2022.105717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105717</ArticleId><ArticleId IdType="pmc">PMC9719844</ArticleId><ArticleId IdType="pubmed">36507225</ArticleId></ArticleIdList></Reference><Reference><Citation>Witkowski M, Tizian C, Ferreira-Gomes M, et al. Untimely TGF&#x3b2; responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021;600:295&#x2013;301. doi: 10.1038/s41586-021-04142-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04142-6</ArticleId><ArticleId IdType="pubmed">34695836</ArticleId></ArticleIdList></Reference><Reference><Citation>Adang EAMC, Strous MTA, van den Bergh JP, Gach D, van Kampen VEM, van Zeeland REP, Barten DG, van Osch FHM. Association of heart rate variability with pulmonary function impairment and symptomatology post-COVID-19 hospitalization. Sensors. 2023;23(5):2473. doi: 10.3390/s23052473.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s23052473</ArticleId><ArticleId IdType="pmc">PMC10007596</ArticleId><ArticleId IdType="pubmed">36904676</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>